Cite
MLA Citation
M J Casanova et al.. “P519 Analysis of the effectiveness and safety of switching from originator to biosimilar adalimumab in patients with Inflammatory Bowel Disease.” Journal of Crohn's and colitis, vol. 16, n.d., pp. i474–i475. http://access.bl.uk/ark:/81055/vdc_100150514768.0x000035